chr12-112978775-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002535.3(OAS2):c.167G>A(p.Gly56Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,278 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002535.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OAS2 | NM_002535.3 | c.167G>A | p.Gly56Glu | missense_variant | 1/10 | ENST00000392583.7 | NP_002526.2 | |
OAS2 | NM_016817.3 | c.167G>A | p.Gly56Glu | missense_variant | 1/11 | NP_058197.2 | ||
OAS2 | NM_001032731.2 | c.167G>A | p.Gly56Glu | missense_variant | 1/2 | NP_001027903.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OAS2 | ENST00000392583.7 | c.167G>A | p.Gly56Glu | missense_variant | 1/10 | 1 | NM_002535.3 | ENSP00000376362 | P2 | |
ENST00000552784.1 | n.353+38624C>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 249954Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135188
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461278Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726890
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.167G>A (p.G56E) alteration is located in exon 1 (coding exon 1) of the OAS2 gene. This alteration results from a G to A substitution at nucleotide position 167, causing the glycine (G) at amino acid position 56 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at